The authors stated that direct exposure to anti-TNFα therapy did not result in increased adverse pregnancy outcomes, but it was worse, compared to pregnancies before inflammatory bowel disease diagnosis [23]. This evidence concerns the gene TNF and inflammatory bowel disease.